KRISTAN HIGGINBOTHAM: Open Payments
NPI 1467715094 · MARION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 36 payments from 11 companies in 2025. Trend: 2023 $387 · 2024 $335 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $210 |
| Axsome Therapeutics, Inc. | 1 | $85 |
| PFIZER INC. | 2 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 4 | $30 |
| Lilly USA, LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, QULIPTA, Auvelity, ZAVZPRET, AIRSUPRA, REXULTI, VOQUEZNA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
